Emergency BU Alert BU Medical Campus OPEN Jan. 28, 2015 Boston University Medical Campus will be open Wednesday, Jan. 28, 2015. BUSM classes will be held as scheduled. Staff should check with their managers regarding work schedules. Medical, PA and GMS students who are assigned to inpatient services or clinics are expected to be present, if possible. Students who are assigned to outpatient services should check with their course director or the policy at the clinical site. GMS classes are canceled. Staff should check with their manager regarding their work schedules. The Henry M. Goldman School of Dental Medicine will follow normal school hours. All Patient Treatment Centers will be open for patient care and all classes will be held as scheduled. BU School of Public Health classes are canceled; SPH non-essential staff may telecommute. Employees who are part of the BUMC parking program should park in your assigned lot or garage. The Boston parking ban is still in effect. For updated information, please call the weather/emergency hotline at 617-638-6886 or visit the BU Emergency Communications website at http://www.bu.edu/ehs/comm/

Scleroderma Clinical Research and Trials

Our patients have the opportunity to participate in a wide variety of clinical trials of novel therapies. Physicians in the Program are active in trial development and design. Recent examples have included trials of agents to treat pulmonary hypertension, digital ulcers, lung disease, skin fibrosis and overall disease therapy. We are also actively enrolling interested patients in a variety of ongoing studies to assess clinical and biologic outcomes in scleroderma. Our program is an active member of the Scleroderma Clinical Trials Consortium (SCTC), an international group that conducts multicenter trials of therapies in scleroderma. Members of the Section hold leadership positions in the SCTC. Our clinical programs also serve as important educational hub for other physicians and trainees to enhance awareness and clinical care in scleroderma.

Active trials change frequently, so please contact us directly for questions about enrolling trials.